Residues in Cdc42 that specify binding to individual CRIB effector proteins

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• Cdc42 is a Rho family GTPase regulating cytoskeletal dynamics, proliferation, and differentiation.
• Specific recognition mechanisms between Cdc42 and its diverse effector proteins remain unclear.
• Understanding these interactions is crucial for deciphering Cdc42-mediated signaling pathways.

Purpose of the Study:

• To investigate the molecular basis of Cdc42's specific binding to its effector proteins.
• To identify key residues in Cdc42 responsible for selective interactions with CRIB domain-containing effectors (ACK, PAK, WASP) and Rho GAP.
• To provide insights into how Cdc42 signaling specificity is achieved.

Main Methods:

• Site-directed mutagenesis was used to introduce mutations at various residues of Cdc42.
• Equilibrium binding constants were measured for wild-type and mutant Cdc42 proteins binding to ACK, PAK, WASP, and Rho GAP.
• Structural analysis of Cdc42 complexes was employed to interpret mutation effects.

Main Results:

• Mutations in the effector loop generally impaired binding to all tested CRIB proteins.
• The F37A mutation demonstrated significant selectivity for CRIB protein binding.
• Residues outside the effector loop, such as V42 and L174, were critical for selective binding to specific effectors (e.g., V42A and L174A disrupted ACK and WASP binding differentially, while not affecting PAK binding).

Conclusions:

• Specific residues outside the effector loop play a key role in conferring selectivity to Cdc42-effector interactions.
• Mutations that selectively alter binding affinities provide valuable tools for dissecting the in vivo roles of specific Cdc42 effectors.
• Structural insights into Cdc42-effector complexes elucidate the molecular basis of signal specificity.